Companies Dominating the Diagnostic Biomarkers Landscape
- Siemens Healthcare GmbH
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- PerkinElmer Inc.
- Biomarker Technologies, Inc.
- Almac Group Limited
- Myriad Genetics, Inc.
- F. Hoffmann-La Roche Ltd
- Epigenomics AG
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- QIAGEN GmbH
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of diagnostic biomarkers is assessed at USD 68.64 billion.
Diagnostic Biomarkers Market size was over USD 62.43 billion in 2024 and is projected to reach USD 263.08 billion by 2037, witnessing around 11.7% CAGR during the forecast period i.e., between 2025-2037.
North America industry is likely to account for largest revenue share by 2037, impelled by efficient healthcare sector, supported by high government investment.
The major players in the market are PerkinElmer Inc., Biomarker Technologies, Inc., Almac Group Limited, Myriad Genetics, Inc., F. Hoffmann-La Roche Ltd, Epigenomics AG, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., QIAGEN GmbH and others.
